Cargando…
Insights into immuno-oncology drug development landscape with focus on bone metastasis
Bone is among the main sites of metastasis in breast, prostate and other major cancers. Bone metastases remain incurable causing high mortality, severe skeletal-related effects and decreased quality of life. Despite the success of immunotherapies in oncology, no immunotherapies are approved for bone...
Autores principales: | Kähkönen, Tiina E., Halleen, Jussi M., MacRitchie, Gary, Andersson, Ronnie M., Bernoulli, Jenni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10355372/ https://www.ncbi.nlm.nih.gov/pubmed/37475868 http://dx.doi.org/10.3389/fimmu.2023.1121878 |
Ejemplares similares
-
Osteoimmuno-Oncology: Therapeutic Opportunities for Targeting Immune Cells in Bone Metastasis
por: Kähkönen, Tiina E., et al.
Publicado: (2021) -
Immunotherapies and Metastatic Cancers: Understanding Utility and Predictivity of Human Immune Cell Engrafted Mice in Preclinical Drug Development
por: Kähkönen, Tiina E., et al.
Publicado: (2020) -
Human Immune System Increases Breast Cancer-Induced Osteoblastic Bone Growth in a Humanized Mouse Model without Affecting Normal Bone
por: Kähkönen, Tiina E., et al.
Publicado: (2019) -
The evolving landscape of predictive biomarkers in immuno‐oncology with a focus on spatial technologies
por: Sadeghi Rad, Habib, et al.
Publicado: (2020) -
Dovitinib dilactic acid reduces tumor growth and tumor-induced bone changes in an experimental breast cancer bone growth model
por: Kähkönen, Tiina E., et al.
Publicado: (2019)